Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19

Blood Research 2021³â 56±Ç 1È£ p.56 ~ p.58

¹ÚÈñ¼ö(Park Hee-Sue) - Chungbuk National University Hospital Department of Labaratory Medicine
½Å°æ¼·(Shin Kyeong-Seob) - Chungbuk National University College of Medicine Department of Laboratory Medicine
¼Õº¸¶ó(Son Bo-Ra) - Chungbuk National University College of Medicine Department of Laboratory Medicine

Abstract

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This article reported coagulopathy-related laboratory findings in patients with non-severe COVID-19. The coagulopathy-related laboratory findings indicate that the coagulation profile should be used to monitor patients until negative conversion for SARS-CoV-2 occurs.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå